159002-15-0Relevant articles and documents
PRODRUGS OF MODULATORS OF THE NMDA RECEPTOR
-
Page/Page column 50-51, (2021/01/23)
The present invention is directed to novel prodrugs of modulators of the NMDA receptor of formula I. Separate aspects of the inventions are directed to pharmaceutical compositions comprising said compounds and uses of the compounds to treat neurological disorders or neuropsychiatric disorders such as depression.
Synthesis of alanine and proline amino acids with amino or guanidinium substitution on the side chain
Zhang, Zhenyu,Aerschot, Arthur Van,Hendrix, Chris,Busson, Roger,David, Frank,Sandra, Pat,Herdewijn, Piet
, p. 2513 - 2522 (2007/10/03)
Competitive binding of peptides containing basic amino acids to disrupt or prevent the Tat-TAR interaction could result in diminished transcription as well as translation and hence constitutes an alternative way of controlling HIV replication. Therefore, we synthesized guanidinium and amino containing amino acids, based on a proline or an alanine scaffold. The introduction of the guanidinium moiety was best accomplished using 1H- pyrazole-1-carboxamidine hydrochloride, with Pmc used for its protection. The absence of racemization, maintained throughout the whole synthesis, was confirmed by chiral purity determination. These building blocks were smoothly incorporated into oligopeptides, which proved their suitability for use in a combinatorial approach for selecting TAR binding ligands. (C) 2000 Elsevier Science Ltd.
Synthesis of crystalline orthogonally N-protected (S)- or (R)-2,3-diaminopropionaldehyde from L- or D-aspartic acid
Schirlin,Altenburger
, p. 1351 - 1352 (2007/10/02)
Procedures are described for the easy preparation of crystalline orthogonally N-protected (S)- or (R)-2,3-diaminopropionaldehyde of high optical purity from L- or D-aspartic acid, respectively, and in reasonable yields.
